Reuters logo
Merger of drugmakers Valeant, Actavis on hold: source
April 27, 2013 / 8:18 PM / 5 years ago

Merger of drugmakers Valeant, Actavis on hold: source

(Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc (VRX.TO) and Actavis Inc ACT.N in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday.

    A Valeant (VRX.N) spokeswoman and an Actavis spokesman could not be immediately reached for comment outside of business hours.

    Reporting by Soyoung Kim in New York; writing by Rod Nickel in Winnipeg, Manitoba

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below